Nicolas M. Barthelemy
Presently, Nicolas M. Barthelemy occupies the position of Executive Chairman at Biocare Medical LLC. Mr. Barthelemy is also on the board of 5 other companies.
In his past career he was Senior Project Engineer-Vaccine Technology at Merck & Co., Inc., Vice President-Manufacturing & General Manager at Biogen, Inc., General Manager of Research Triangle Park, President & Chief Executive Officer for Biotheranostics, Inc., President-Cell Systems Division at Invitrogen Corp. and President-Global Commercial Operations at Life Technologies Corp.
He received a graduate degree from the University of California, Berkeley and an undergraduate degree from École Supérieure de Physique et de Chimie de Paris.
|05/13/2021||457||Award at $0 per share.||0|
|11/09/2020||1,214||Disposition at $195.51 per share.||237,350|
|05/18/2020||3,009||Disposition at $142.53 per share.||428,873|
|05/18/2020||2,109||Derivative/Non-derivative trans. at $67.71 per share.||142,800|
|05/13/2020||527||Award at $0 per share.||0|
|04/22/2020||2,688||Disposition at $109.99 per share.||295,654|
|04/22/2020||1,652||Derivative/Non-derivative trans. at $42.07 per share.||69,499|
|04/03/2020||2,688||Disposition at $99.99 per share.||268,774|
|04/03/2020||1,652||Derivative/Non-derivative trans. at $42.07 per share.||69,499|
|05/15/2019||923||Award at $0 per share.||0|
|08/29/2018||6,580||Disposition at $54.44 per share.||358,216|
|08/29/2018||1,992||Derivative/Non-derivative trans. at $41.19 per share.||82,050|
|08/29/2018||2,434||Derivative/Non-derivative trans. at $38.76 per share.||94,341|
|05/16/2018||1,486||Award at $0 per share.||0|
|05/09/2018||26,500||Disposition at $40.54 per share.||1,074,310|
|05/09/2018||3,366||Derivative/Non-derivative trans. at $26.12 per share.||87,919|
|05/09/2018||24,000||Derivative/Non-derivative trans. at $20.37 per share.||488,880|
|05/18/2017||1,206||Award at $0 per share.||0|